Usage of ceftazidime is indicated in the treatment of pneumonia, urinary tract infections, intra-abdominal infections, gynecological infections, lower respiratory tract infections, bacterial septicemia, bone and joint-related infections, meningitis, and skin-related infections.

Mild to moderate side effects have been observed, such as redness, swelling, and pain at the injection site; nausea, vomiting, diarrhea, abdominal pain, and, in some cases, dizziness; pruritus, rash, and phlebitis.

This medication is to be used cautiously in patients with seizure disorders, encephalopathy, neuromuscular excitability or disorders, or patients with increased prothrombin time.

This drug is contraindicated in patients with a known history of hypersensitivity to cephalosporins.

Adults are usually given 1 gram intravenously or intramuscularly. 8 -12 hourly.

We have established our roots in other countries as well, such as Saudi Arabia.Libya, Belize, Côte d’Ivoire, Ecuador, Eritrea

Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai